News

Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...
These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...
Wegovy, a weight loss drug made famous by celebrities around the world, is on New Zealand pharmacists' shelves, but it is ...
These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...
For CVS Health CVS, the key to building customer trust is to enhance access to life-changing medications and also make them affordable. Beginning July 1, the company’s Pharmacy Benefit Manager (“PBM”) ...
UnitedHealth Group’s ( UNH) new CEO, Stephen Hemsley, is shaking up the senior management of the company, appointing Patrick Conway, newly named CEO of the managed care giant’s Optum unit, as the head ...
A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...
San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...
These six stocks span numerous sectors, providing investors with opportunities in both growth and dividend yield.
Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...
Under the deal, cash-paying patients can access a month’s supply of Wegovy through the Danish drugmaker’s Novocare pharmacy for $299. The one-time price will also be available through Novo’s other ...
Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...